Long-Term Follow Up Study of Subjects Previously Administered HMI 102
Conditions: Phenylketonuria; PAH Deficiency Intervention: Genetic: HMI-102 Sponsor: Homology Medicines, Inc Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2020 Category: Research Source Type: clinical trials